This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Biogen MA Inc.
Biogen MA Inc., commonly referred to as Biogen, is a leading biotechnology company headquartered in the United States. Founded in 1978, Biogen has established itself as a pioneer in the development of therapies for neurological diseases, with a strong focus on multiple sclerosis, spinal muscular atrophy, and Alzheimer’s disease. With major operational regions across North America, Europe, and Asia, Biogen is renowned for its innovative products, including the first approved treatment for spinal muscular atrophy. The company’s commitment to research and development has positioned it as a key player in the biotechnology industry, achieving significant milestones such as the launch of groundbreaking therapies that address unmet medical needs. Biogen's dedication to advancing neuroscience continues to drive its market leadership and influence in the biopharmaceutical sector.
DitchCarbon Score
How does Biogen MA Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Biogen MA Inc.'s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Biogen MA Inc., headquartered in the US, currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Biogen Inc., which may influence its climate commitments and reporting practices. While no specific reduction targets or achievements are available for Biogen MA Inc., it is important to note that the company inherits its climate initiatives from its parent organisation, Biogen Inc. This includes participation in various sustainability initiatives such as the Science Based Targets initiative (SBTi), CDP, and RE100, all of which are cascaded from Biogen Inc. at a corporate family level. Biogen Inc. has made commitments to reduce its carbon footprint and enhance sustainability practices, although specific targets for Biogen MA Inc. are not detailed. The absence of direct emissions data suggests that the company may still be in the process of establishing its own reporting framework or may rely on aggregated data from its parent company. In summary, while Biogen MA Inc. does not currently provide specific emissions data or reduction targets, it is aligned with the broader sustainability efforts of Biogen Inc., which are aimed at addressing climate change and reducing overall carbon emissions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 60,179,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 187,000 | 000,000 | 00,000 | 00,000 | 000,000 | 000,000 | 000,000 | 000,000 | 000,000 | 000,000 |
| Scope 3 | 262,358,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Biogen MA Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
